Single dose epidural hydromorphone in labour pain: maternal pharmacokinetics and neonatal exposure.

Introduction: Epidural hydromorphone could be useful in obstetric analgesia as there is a need for a more water-soluble opioid than sufentanil or fentanyl with prolonged analgesic effect. To our knowledge, the pharmacokinetics of epidural hydromorphone has not been evaluated in parturients. Material...

Descripción completa

Detalles Bibliográficos
Publicado en:European Journal of Clinical Pharmacology Vol. 76; no. 7; pp. 969 - 978
Autores principales: Puhto, Terhi, Kokki, Merja, Hakomäki, Henriikka, Spalding, Michael, Gunnar, Teemu, Alahuhta, Seppo, Vakkala, Merja
Formato: research tables/charts Journal Article
Publicado: Springer Nature Jul2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=143875500&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 143875500
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00316970
        NP9
      jtl: European Journal of Clinical Pharmacology
      issn: 00316970
      maglogo: N
    pubinfo:
      dt: Jul2020
      vid: 76
      iid: 7
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        143875500
        143875500
        143937121
        143875500
        10.1007/s00228-020-02880-6
        143875500
      ppf: 969
      ppct: 9
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Single dose epidural hydromorphone in labour pain: maternal pharmacokinetics and neonatal exposure.
      aug:
        au:
          Puhto, Terhi
          Kokki, Merja
          Hakomäki, Henriikka
          Spalding, Michael
          Gunnar, Teemu
          Alahuhta, Seppo
          Vakkala, Merja
        affil: Department of Anaesthesiology, Medical Research Center Oulu (MRC Oulu), Oulu University Hospital, PO Box 21, 90029, Oulu, Finland
      sug:
        subj:
          Analgesia, Epidural
          Analgesia, Obstetrical
          Dihydromorphinone Administration and Dosage
          Labor Pain Prevention and Control
          Pain Management
          Dihydromorphinone Pharmacokinetics
          Neonatal Assessment
          Human
          Pilot Studies
          Nausea Diagnosis
          Pruritus Diagnosis
          Adverse Drug Event
          Dihydromorphinone Blood
          Umbilical Veins Analysis
          Umbilical Arteries Analysis
          Apgar Score
          Scales
          Bupivacaine Administration and Dosage
          Analgesics, Opioid Adverse Effects
          Treatment Outcomes
      ab: Introduction: Epidural hydromorphone could be useful in obstetric analgesia as there is a need for a more water-soluble opioid than sufentanil or fentanyl with prolonged analgesic effect. To our knowledge, the pharmacokinetics of epidural hydromorphone has not been evaluated in parturients. Materials and methods: In this pilot study, seven healthy parturients were given a single epidural dose of hydromorphone for labour pain. One parturient received 1.5 mg, two 0.75 mg and four 0.5 mg of hydromorphone hydrochloride. Dose was decreased due to nausea and pruritus. Hydromorphone's effect, adverse effects and plasma concentrations were evaluated. Neonatal drug exposure was evaluated by umbilical vein and artery opioid concentration at birth. Neonatal outcomes were assessed using Apgar and the Neurologic Adaptive Capacity Score (NACS). Results: All patients received additional levobupivacaine doses on parturients' requests. The first dose was requested at a median of 163 min (range 19–303 min) after hydromorphone administration. A total of 12 opioid related expected adverse events were reported by seven parturients. All newborn outcomes were uneventful. Hydromorphone's distribution and elimination after single epidural dose seem similar to that reported for non-pregnant subjects after intravenous hydromorphone administration, but further research is required to confirm this observation. Conclusions: The optimal dose of hydromorphone in labour pain warrants further evaluation.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N